Literature DB >> 12906377

Subclinical thyroid disorders: the menace of the Trojan horse.

L H Duntas1.   

Abstract

This review aims at summarizing some new data regarding the so-called subclinical thyroid disease and incorporate the knowledge in order to provide a basis for a more careful approach to these morbidities. SHyper represents a considerable risk factor for atrial fibrillation in the elderly and also for osteoporosis, which is a major cause of morbidity in postmenopausal women. SHypo is not an innocuous condition. It progresses to thyroid failure in patients with positive thyroid antibodies, it affects neurobehavior, it may influence cardiac contractility at exercise and it is associated with an impaired lipid profile that may provoke atherosclerosis. Therefore, both conditions should be screened more carefully in the community and treatment should be more often considered.

Entities:  

Mesh:

Year:  2003        PMID: 12906377     DOI: 10.1007/BF03345205

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  83 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  The treatment of subclinical hypothyroidism is seldom necessary.

Authors:  J W Chu; L M Crapo
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

3.  A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism.

Authors:  E Nyström; K Caidahl; G Fager; C Wikkelsö; P A Lundberg; G Lindstedt
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

4.  Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.

Authors:  J Faber; I W Jensen; L Petersen; B Nygaard; L Hegedüs; K Siersbaek-Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  1998-03       Impact factor: 3.478

5.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Authors:  J Auer; P Scheibner; T Mische; W Langsteger; O Eber; B Eber
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

Review 6.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

7.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Authors:  C Meier; J J Staub; C B Roth; M Guglielmetti; M Kunz; A R Miserez; J Drewe; P Huber; R Herzog; B Müller
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

8.  Stapedial reflex: a biological index found to be abnormal in clinical and subclinical hypothyroidism.

Authors:  D G Goulis; N Tsimpiris; S Delaroudis; B Maltas; M Tzoiti; A Dagilas; A Avramides
Journal:  Thyroid       Date:  1998-07       Impact factor: 6.568

9.  Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

Authors:  J Faber; A M Galløe
Journal:  Eur J Endocrinol       Date:  1994-04       Impact factor: 6.664

10.  Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.

Authors:  F Pazos; J J Alvarez; J Rubiés-Prat; C Varela; M A Lasunción
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

View more
  2 in total

1.  Perturbation of lipids and glucose metabolism associated with previous 2,4-D exposure: a cross-sectional study of NHANES III data, 1988-1994.

Authors:  Dina M Schreinemachers
Journal:  Environ Health       Date:  2010-02-26       Impact factor: 5.984

2.  Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001-2002, a Cross-Sectional, Hypothesis-Generating Study.

Authors:  Dina M Schreinemachers
Journal:  Biomark Insights       Date:  2011-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.